Demo Sign up Log In

Nuo Therapeutics, Inc. (AURX)

Cash & Equivalents

$449.33K

Quarterly · Period ending: Jun 30, 2026 · USD

AURX Cash & Equivalents

Latest reported$548.95Kperiod endingDec 31, 2025

Latest reported$548.95Kperiod endingDec 31, 2025

AURX FY Cash & Equivalents ($123.80K → $548.95K)

Annual Cash & Equivalents

High-resolution chart · PNG

AURX cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Cash & Equivalents — Annual fiscal periods (USD)
Period ending	Cash & Equivalents (USD)
Dec 31, 2025	548,946
Dec 31, 2024	283,714
Dec 31, 2023	928,681
Dec 31, 2022	2,051,208
Dec 31, 2021	148,430
Dec 31, 2020	151,585
Dec 31, 2019	157,264
Dec 31, 2018	636,927
Dec 31, 2017	693,515
Dec 31, 2016	2,673,513
Dec 31, 2015	922,317
Dec 31, 2014	15,946,425
Dec 31, 2013	3,286,713
Dec 31, 2012	2,615,805
Dec 31, 2011	2,246,050
Dec 31, 2010	638,868
Dec 31, 2009	2,107,499
Dec 31, 2008	4,027,026
Dec 31, 2007	5,136,446
Dec 31, 2006	4,662,199
Dec 31, 2005	3,123,927
Dec 31, 2004	3,274,934
Dec 31, 2003	811,385
Dec 31, 2002	945,298
Dec 31, 2001	184,395
Dec 31, 2000	2,116,232
Dec 31, 1999	123,795

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.